BRISTOL-MYERS SQUIBB COMPANY Marketable Securities (Non-Current)
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Marketable Securities (Non-Current) of $0 as of 2021-12-31, per its 10-K filed 2022-02-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2022-02-09
- 2021-12-31: Marketable Securities, Noncurrent $0.00.
- 2021-09-30: Marketable Securities, Noncurrent $46.00M.
- 2021-06-30: Marketable Securities, Noncurrent $143.00M.
- 2021-03-31: Marketable Securities, Noncurrent $288.00M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-09 |
| 2021-09-30 | $46.00M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $143.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $288.00M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $433.00M 10-K · filed 2022-02-09 |
| 2020-09-30 | $495.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $523.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $651.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $767.00M 10-K · filed 2021-02-10 |
| 2019-09-30 | $925.00M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $994.00M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $1.23B 10-Q · filed 2019-04-25 |
| 2018-12-31 | $1.77B 10-K · filed 2020-02-24 |
| 2018-09-30 | $2.02B 10-Q · filed 2018-10-25 |
| 2018-06-30 | $2.12B 10-Q · filed 2018-07-26 |
| 2018-03-31 | $2.25B 10-Q · filed 2018-04-26 |
| 2017-12-31 | $2.48B 10-K · filed 2019-02-25 |
| 2017-09-30 | $2.53B 10-Q · filed 2017-10-26 |
| 2017-06-30 | $2.58B 10-Q · filed 2017-07-27 |
| 2017-03-31 | $2.69B 10-Q · filed 2017-04-27 |
| 2016-12-31 | $2.72B 10-K · filed 2018-02-13 |
| 2016-09-30 | $3.04B 10-Q · filed 2016-10-27 |
| 2016-06-30 | $3.28B 10-Q · filed 2016-07-28 |
| 2016-03-31 | $3.69B 10-Q · filed 2016-04-28 |
| 2015-12-31 | $4.66B 10-K · filed 2017-02-21 |
| 2015-09-30 | $4.63B 10-Q · filed 2015-10-27 |
| 2015-06-30 | $4.63B 10-Q · filed 2015-07-23 |
| 2015-03-31 | $4.28B 10-Q · filed 2015-04-28 |
| 2014-12-31 | $4.41B 10-K · filed 2016-02-12 |
| 2014-09-30 | $4.33B 10-Q · filed 2014-10-24 |
| 2014-06-30 | $3.88B 10-Q · filed 2014-07-24 |
| 2014-03-31 | $3.56B 10-Q · filed 2014-04-29 |
| 2013-12-31 | $3.75B 10-K · filed 2015-02-13 |
| 2013-09-30 | $3.62B 10-Q · filed 2013-10-23 |
| 2013-06-30 | $3.22B 10-Q · filed 2013-07-25 |
| 2013-03-31 | $3.24B 10-Q · filed 2013-04-25 |
| 2012-12-31 | $3.52B 10-K · filed 2014-02-14 |
| 2012-09-30 | $3.70B 10-Q · filed 2012-10-24 |
| 2012-06-30 | $3.73B 10-Q · filed 2012-07-25 |
| 2012-03-31 | $3.58B 10-Q · filed 2012-04-26 |
| 2011-12-31 | $2.91B 10-K · filed 2013-02-15 |
| 2011-09-30 | $2.82B 10-Q · filed 2011-10-27 |
| 2011-06-30 | $2.73B 10-Q · filed 2011-07-28 |
| 2011-03-31 | $3.06B 10-Q · filed 2011-04-28 |
| 2010-12-31 | $2.68B 10-K · filed 2012-02-17 |
| 2010-09-30 | $2.56B 10-Q · filed 2010-10-26 |
| 2010-06-30 | $2.79B 10-Q · filed 2010-07-22 |
| 2010-03-31 | $3.00B 10-Q · filed 2010-04-29 |
| 2009-12-31 | $1.37B 10-K · filed 2011-02-18 |
| 2009-09-30 | $1.20B 10-Q · filed 2009-10-22 |
| 2009-06-30 | $983.00M 10-Q · filed 2009-07-23 |
| 2008-12-31 | $188.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |